IbuprofenAspirinAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-NarcoticPlatelet Aggregation InhibitorsAcetaminophenEarly Detection of CancerNaproxenThromboxane B2Prostatic NeoplasmsOvarian NeoplasmsDiclofenacBreast NeoplasmsColonic NeoplasmsLung NeoplasmsDose-Response Relationship, DrugStomach NeoplasmsCyclooxygenase 2 InhibitorsSalicylatesProspective StudiesNeoplasm MetastasisDouble-Blind MethodAntipyreticsNeoplasm InvasivenessTiclopidineNeoplasmsPancreatic NeoplasmsDrug Therapy, CombinationFollow-Up StudiesProstaglandin-Endoperoxide SynthasesPlatelet AggregationRiskMice, NudeGene Expression Regulation, NeoplasticDuctus Arteriosus, PatentCancer VaccinesIndomethacinRisk FactorsCyclooxygenase 1Treatment OutcomeCyclooxygenase 2Risk AssessmentRetrospective StudiesNeoplasm ProteinsColorectal NeoplasmsSurvival AnalysisDrug Administration ScheduleSurvival RatePrognosisAntineoplastic AgentsSodium SalicylateAdministration, OralUterine Cervical NeoplasmsGenetic Predisposition to DiseaseCell Line, TumorKetoprofenThromboxanesTherapeutic EquivalencyReverse Transcriptase Polymerase Chain ReactionPlatelet Function TestsUrinary Bladder NeoplasmsUnited StatesCarcinomaRegistriesDisease ProgressionAntineoplastic Combined Chemotherapy ProtocolsCarcinoma, Squamous CellXenograft Model Antitumor AssaysTime FactorsDrug Resistance, NeoplasmOdds RatioCarcinoma, Non-Small-Cell LungRNA, MessengerNational Cancer Institute (U.S.)SulfonesLactonesDrug InteractionsAge FactorsBlood PlateletsDinoprostoneMutationReceptors, EstrogenGene Expression Profiling